EDGAR Filing Documents for 0001144204-15-026697

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001144204-15-026697

Filing Date

2015-05-01

Accepted

2015-04-30 17:33:51

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	v409045_sc13d.htm	SC 13D	48040
2	EXHIBIT 99.1	v409045_ex99-1.htm	EX-99.1	40776
3	EXHIBIT 99.2	v409045_ex99-2.htm	EX-99.2	48768
4	EXHIBIT 99.3	v409045_ex99-3.htm	EX-99.3	45995
5	EXHIBIT 99.4	v409045_ex99-4.htm	EX-99.4	171452
	Complete submission text file	0001144204-15-026697.txt		356207

Mailing Address 949 FELL STREET BALTIMORE MD 21231

Business Address 949 FELL STREET BALTIMORE MD 21231 410-387-4000

VACCINOGEN INC (Subject) CIK: 0001453001 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: SC 13D | Act: 34 | File No.: 005-87974 | Film No.: 15820627
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5300 WESTVIEW DRIVE SUITE 406 FREDERICK MD 21703

Business Address

TUSSING ANDREW (Filed by) CIK: 0001585095 (see all company filings)

Type: SC 13D